{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:51:37Z","timestamp":1787010697841,"version":"build-2736575974"},"posted":{"date-parts":[[2023,12,24]]},"group-title":"Radiology and Imaging","reference-count":73,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Focused ultrasound (FUS) in combination with microbubbles has recently shown great promise in facilitating blood-brain barrier (BBB) opening for drug delivery and immunotherapy in Alzheimer\u2019s disease (AD). However, it is currently limited to systems integrated within the MRI suites or requiring post-surgical implants, thus restricting its widespread clinical adoption. In this pilot study, we investigate the clinical safety and feasibility of a portable, non-invasive neuronavigation-guided FUS (NgFUS) system with integrated real-time 2-D microbubble cavitation mapping.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    A phase 1 clinical study with mild to moderate AD patients (N=6) underwent a single session of microbubble-mediated NgFUS to induce transient BBB opening (BBBO). Microbubble activity under FUS was monitored with real-time 2-D cavitation maps and dosing to ensure the efficacy and safety of the NgFUS treatment. Post-operative MRI was used for BBB opening and closure confirmation as well as safety assessment. Changes in AD biomarker levels in both blood serum and extracellular vesicles (EVs) were evaluated, while changes in amyloid-beta (A\u03b2) load in the brain were assessed through\n                    <jats:sup>18<\/jats:sup>\n                    F-Florbetapir PET.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    BBBO was achieved in 5 out of 6 subjects with an average volume of 983\u00b1626 mm\n                    <jats:sup>3<\/jats:sup>\n                    following FUS at the right frontal lobe both in white and gray matter regions. The outpatient treatment was completed within 34.8\u00b110.7 min. Cavitation dose significantly correlated with the BBBO volume (\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    &gt;0.9,\n                    <jats:italic>N<\/jats:italic>\n                    =4), demonstrating the portable NgFUS system\u2019s capability of predicting opening volumes. The cavitation maps co-localized closely with the BBBO location, representing the first report of real-time transcranial 2-D cavitation mapping in the human brain. Larger opening volumes correlated with increased levels of AD biomarkers, including A\u03b242 (\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    =0.74), Tau (\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    =0.95), and P-Tau181 (\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    =0.86), assayed in serum-derived EVs sampled 3 days after FUS (\n                    <jats:italic>N<\/jats:italic>\n                    =5). From PET scans, subjects showed a lower A\u03b2 load increase in the treated frontal lobe region compared to the contralateral region. Reduction in asymmetry standardized uptake value ratios (SUVR) correlated with the cavitation dose (\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    &gt;0.9,\n                    <jats:italic>N<\/jats:italic>\n                    =3). Clinical changes in the mini-mental state examination over 6 months were within the expected range of cognitive decline with no additional changes observed as a result of FUS.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We showed the safety and feasibility of this cost-effective and time-efficient portable NgFUS treatment for BBBO in AD patients with the first demonstration of real-time 2-D cavitation mapping. The cavitation dose correlated with BBBO volume, a slowed increase in pathology, and serum detection of AD proteins. Our study highlights the potential for accessible FUS treatment in AD, with or without drug delivery.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.12.21.23300222","type":"posted-content","created":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T14:10:17Z","timestamp":1703427017000},"source":"Crossref","is-referenced-by-count":8,"title":["Transcranial Blood\u2013Brain Barrier Opening in Alzheimer\u2019s Disease Patients Using a Portable Focused Ultrasound System with Real-Time 2-D Cavitation Mapping"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-8677","authenticated-orcid":false,"given":"Sua","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-4692","authenticated-orcid":false,"given":"Keyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-1495","authenticated-orcid":false,"given":"Antonios N.","family":"Pouliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1361-141X","authenticated-orcid":false,"given":"Robin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2307-1744","authenticated-orcid":false,"given":"Sergio","family":"Jim\u00e9nez-Gamb\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5990-3744","authenticated-orcid":false,"given":"Omid","family":"Yousefian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4691-4443","authenticated-orcid":false,"given":"Alina R.","family":"Kline-Schoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6979-9389","authenticated-orcid":false,"given":"Alec J.","family":"Batts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios N.","family":"Tsitsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-3728","authenticated-orcid":false,"given":"Danae","family":"Kokossis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-3086","authenticated-orcid":false,"given":"Akiva","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-2265","authenticated-orcid":false,"given":"Lawrence S.","family":"Honig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-7936","authenticated-orcid":false,"given":"Elisa E.","family":"Konofagou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2024050903450681000_2023.12.21.23300222v5.1","first-page":"1","article-title":"2022 Alzheimer\u2019s disease facts and figures","volume":"18","author":"Alzheimer\u2019s Association","year":"2022","journal-title":"Alzheimer\u2019s Dement"},{"key":"2024050903450681000_2023.12.21.23300222v5.2","first-page":"197","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer\u2019s disease","volume":"9","year":"2022","journal-title":"Journal of Prevention of Alzheimer\u2019s Disease"},{"key":"2024050903450681000_2023.12.21.23300222v5.3","doi-asserted-by":"crossref","unstructured":"van Dyck CH , Swanson CJ , Aisen P , et al. Lecanemab in Early Alzheimer\u2019s Disease. Vol. 388, The New England Journal of Medicine. Krause und Pachernegg GmbH; 2023.","DOI":"10.1056\/NEJMoa2212948"},{"key":"2024050903450681000_2023.12.21.23300222v5.4","unstructured":"Mintun M , Solomon P , Sims JR , et al. Donanemab in early symptomatic Alzheimer\u2019s disease: Efficacy and safety in TRAILBLAZER-ALZ 2, a phase 3 randomized clinical trial. In: Alzheimer\u2019s Association International Conference. Amsterdam;"},{"key":"2024050903450681000_2023.12.21.23300222v5.5","doi-asserted-by":"publisher","DOI":"10.3390\/PH13090214"},{"key":"2024050903450681000_2023.12.21.23300222v5.6","doi-asserted-by":"crossref","unstructured":"Banks WA , Terrell B , Farr SA , Robinson SM , Nonaka N , Morley JE . Passage of amyloid protein antibody across the blood-brain barrier in a mouse model of Alzheimer\u2019s disease. Vol. 23, Peptides. 2002.","DOI":"10.1016\/S0196-9781(02)00261-9"},{"key":"2024050903450681000_2023.12.21.23300222v5.7","first-page":"1","article-title":"The blood-brain barrier: Physiology and strategies for drug delivery","volume":"165\u2013166","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"2024050903450681000_2023.12.21.23300222v5.8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-062117-121238"},{"key":"2024050903450681000_2023.12.21.23300222v5.9","doi-asserted-by":"crossref","unstructured":"Chen L , Cruz E , Oikari LE , Padmanabhan P , Song J , G\u00f6tz J . Opportunities and challenges in delivering biologics for Alzheimer\u2019s disease by low-intensity ultrasound. Vol. 189, Advanced Drug Delivery Reviews. Elsevier B.V.; 2022.","DOI":"10.1016\/j.addr.2022.114517"},{"key":"2024050903450681000_2023.12.21.23300222v5.10","doi-asserted-by":"publisher","DOI":"10.7150\/thno.5576"},{"key":"2024050903450681000_2023.12.21.23300222v5.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2011.09.013"},{"key":"2024050903450681000_2023.12.21.23300222v5.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2020.01.002"},{"key":"2024050903450681000_2023.12.21.23300222v5.13","doi-asserted-by":"crossref","first-page":"e10329","DOI":"10.1002\/btm2.10329","article-title":"Transcriptional signature in microglia isolated from an Alzheimer\u2019s disease mouse model treated with scanning ultrasound","volume":"8","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"2024050903450681000_2023.12.21.23300222v5.14","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.7150\/thno.79898","article-title":"Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer\u2019s mice and patients","volume":"13","year":"2023","journal-title":"Theranostics [Internet]"},{"key":"2024050903450681000_2023.12.21.23300222v5.15","doi-asserted-by":"publisher","DOI":"10.3390\/neuroglia4020010"},{"key":"2024050903450681000_2023.12.21.23300222v5.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02974-x"},{"key":"2024050903450681000_2023.12.21.23300222v5.17","doi-asserted-by":"crossref","unstructured":"Park SH , Baik K , Jeon S , Chang WS , Ye BS , Chang JW . Extensive frontal focused ultrasound mediated blood-brain barrier opening for the treatment of Alzheimer\u2019s disease: a proof-of-concept study. Transl Neurodegener. 2021; 10.","DOI":"10.1186\/s40035-021-00269-8"},{"key":"2024050903450681000_2023.12.21.23300222v5.18","first-page":"275","article-title":"Focused ultrasound\u2013mediated blood-brain barrier opening in Alzheimer\u2019s disease: long-term safety, imaging, and cognitive outcomes","volume":"139","year":"2022","journal-title":"J Neurosurg [Internet]"},{"key":"2024050903450681000_2023.12.21.23300222v5.19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac459"},{"key":"2024050903450681000_2023.12.21.23300222v5.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12426-9"},{"key":"2024050903450681000_2023.12.21.23300222v5.21","doi-asserted-by":"crossref","unstructured":"Gasca-Salas C , Fern\u00e1ndez-Rodr\u00edguez B , Pineda-Pardo JA , et al. Blood-brain barrier opening with focused ultrasound in Parkinson\u2019s disease dementia. Nat Commun. 2021; 12.","DOI":"10.1038\/s41467-021-21022-9"},{"key":"2024050903450681000_2023.12.21.23300222v5.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36340-0"},{"key":"2024050903450681000_2023.12.21.23300222v5.23","doi-asserted-by":"crossref","unstructured":"Anastasiadis P , Gandhi D , Guo Y , et al. Localized blood-brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions-controlled focused ultrasound. Proc Natl Acad Sci U S A. 2021; 118.","DOI":"10.1073\/pnas.2103280118"},{"key":"2024050903450681000_2023.12.21.23300222v5.24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj4011"},{"key":"2024050903450681000_2023.12.21.23300222v5.25","doi-asserted-by":"crossref","unstructured":"D\u2019Haese PF , Ranjan M , Song A , et al. \u03b2-Amyloid plaque reduction in the hippocampus after focused ultrasound-Induced blood\u2013brain barrier opening in Alzheimer\u2019s disease. Front Hum Neurosci. 2020; 14.","DOI":"10.3389\/fnhum.2020.593672"},{"key":"2024050903450681000_2023.12.21.23300222v5.26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMoa2308719","article-title":"Ultrasound blood\u2013brain barrier opening and Aducanumab in Alzheimer\u2019s disease","volume":"390","year":"2024","journal-title":"New England Journal of Medicine [Internet]"},{"key":"2024050903450681000_2023.12.21.23300222v5.27","doi-asserted-by":"crossref","unstructured":"Epelbaum S , Burgos N , Canney M , et al. Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer\u2019s disease with an implantable ultrasound device. Alzheimers Res Ther. 2022; 14.","DOI":"10.1186\/s13195-022-00981-1"},{"key":"2024050903450681000_2023.12.21.23300222v5.28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/jpm12020250","article-title":"Short-term efficacy of transcranial focused ultrasound to the hippocampus in Alzheimer\u2019s disease: A preliminary study","volume":"12","year":"2022","journal-title":"J Pers Med [Internet]"},{"key":"2024050903450681000_2023.12.21.23300222v5.29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd0772"},{"key":"2024050903450681000_2023.12.21.23300222v5.30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.21037\/atm-20-344","article-title":"Neuronavigation-guided focused ultrasound (NaviFUS) for transcranial blood-brain barrier opening in recurrent glioblastoma patients: clinical trial protocol","volume":"8","year":"2020","journal-title":"Ann Transl Med"},{"key":"2024050903450681000_2023.12.21.23300222v5.31","doi-asserted-by":"publisher","DOI":"10.14366\/usg.20138"},{"key":"2024050903450681000_2023.12.21.23300222v5.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2019.09.010"},{"key":"2024050903450681000_2023.12.21.23300222v5.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94188-3"},{"key":"2024050903450681000_2023.12.21.23300222v5.34","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1109\/TBME.2023.3266952","article-title":"Real-time passive acoustic mapping with enhanced spatial resolution in neuronavigation-guided focused ultrasound for blood-brain barrier opening","volume":"70","year":"2023","journal-title":"IEEE Trans Biomed Eng"},{"key":"2024050903450681000_2023.12.21.23300222v5.35","doi-asserted-by":"crossref","unstructured":"Marchi N , Cavaglia M , Fazio V , Bhudia S , Hallene K , Janigro D . Peripheral markers of blood-brain barrier damage. Vol. 342, Clinica Chimica Acta. 2004.","DOI":"10.1016\/j.cccn.2003.12.008"},{"key":"2024050903450681000_2023.12.21.23300222v5.36","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3390\/pharmaceutics14122607","article-title":"Cavitation feedback control of focused ultrasound blood-brain barrier opening for drug delivery in patients with Parkinson\u2019s disease","volume":"14","year":"2022","journal-title":"Pharmaceutics [Internet]"},{"key":"2024050903450681000_2023.12.21.23300222v5.37","doi-asserted-by":"crossref","unstructured":"Wu SY , Sanchez CS , Samiotaki G , Buch A , Ferrera VP , Konofagou EE . Characterizing focused-ultrasound mediated drug delivery to the heterogeneous primate brain in vivo with acoustic monitoring. Sci Rep. 2016; 6.","DOI":"10.1038\/srep37094"},{"key":"2024050903450681000_2023.12.21.23300222v5.38","doi-asserted-by":"publisher","DOI":"10.1109\/TUFFC.2017.2681695"},{"key":"2024050903450681000_2023.12.21.23300222v5.39","doi-asserted-by":"publisher","DOI":"10.1121\/1.1912301"},{"key":"2024050903450681000_2023.12.21.23300222v5.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)02637-3"},{"key":"2024050903450681000_2023.12.21.23300222v5.41","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2012-3652"},{"key":"2024050903450681000_2023.12.21.23300222v5.42","doi-asserted-by":"crossref","unstructured":"Zhou H , Liu Y , Long X , et al. Feasibility of ultrasound-induced blood-brain barrier disruption with a single-element transducer under three different frequencies in two non-human primates in vivo: Case report. J Neurosci Methods. 2022; 365.","DOI":"10.1016\/j.jneumeth.2021.109383"},{"key":"2024050903450681000_2023.12.21.23300222v5.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0312-z"},{"key":"2024050903450681000_2023.12.21.23300222v5.44","doi-asserted-by":"crossref","unstructured":"Ye D , Chen S , Liu Y , et al. Mechanically manipulating glymphatic transport by ultrasound combined with microbubbles. Proc Natl Acad Sci U S A. 2023; 120.","DOI":"10.1073\/pnas.2212933120"},{"key":"2024050903450681000_2023.12.21.23300222v5.45","doi-asserted-by":"crossref","unstructured":"Lee Y , Choi Y , Park EJ , et al. Improvement of glymphatic\u2013lymphatic drainage of beta-amyloid by focused ultrasound in Alzheimer\u2019s disease model. Sci Rep. 2020; 10.","DOI":"10.1038\/s41598-020-73151-8"},{"key":"2024050903450681000_2023.12.21.23300222v5.46","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25604"},{"key":"2024050903450681000_2023.12.21.23300222v5.47","first-page":"645","article-title":"Blood-brain barrier opening with MRI-guided focused ultrasound elicits meningeal venous permeability in humans with early Alzheimer disease","volume":"298","year":"2021","journal-title":"Radiology"},{"key":"2024050903450681000_2023.12.21.23300222v5.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.07.042"},{"key":"2024050903450681000_2023.12.21.23300222v5.49","doi-asserted-by":"publisher","DOI":"10.1121\/1.3646905"},{"key":"2024050903450681000_2023.12.21.23300222v5.50","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17753514"},{"key":"2024050903450681000_2023.12.21.23300222v5.51","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1121\/1.4958991","article-title":"Sum-of-harmonics method for improved narrowband and broadband signal quantification during passive monitoring of ultrasound therapies","volume":"140","year":"2016","journal-title":"J Acoust Soc Am"},{"key":"2024050903450681000_2023.12.21.23300222v5.52","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/60\/23\/9079"},{"key":"2024050903450681000_2023.12.21.23300222v5.53","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.ultrasmedbio.2019.07.004","article-title":"Correlation between brain tissue damage and inertial cavitation dose quantified using passive cavitation imaging","volume":"45","year":"2019","journal-title":"Ultrasound Med Biol [Internet]"},{"key":"2024050903450681000_2023.12.21.23300222v5.54","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11111417"},{"key":"2024050903450681000_2023.12.21.23300222v5.55","doi-asserted-by":"publisher","DOI":"10.7150\/thno.47281"},{"key":"2024050903450681000_2023.12.21.23300222v5.56","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ultrasmedbio.2019.04.005","article-title":"Non-linear acoustic emissions from therapeutically driven contrast agent microbubbles","volume":"45","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"2024050903450681000_2023.12.21.23300222v5.57","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa2512"},{"key":"2024050903450681000_2023.12.21.23300222v5.58","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140245"},{"key":"2024050903450681000_2023.12.21.23300222v5.59","doi-asserted-by":"publisher","DOI":"10.1093\/NEUONC\/NOAB057"},{"key":"2024050903450681000_2023.12.21.23300222v5.60","doi-asserted-by":"crossref","unstructured":"Pacia CP , Yuan J , Yue Y , et al. Focused ultrasound\u2013mediated liquid biopsy in a tauopathy mouse model. Radiology. 2023; 307.","DOI":"10.1148\/radiol.220869"},{"key":"2024050903450681000_2023.12.21.23300222v5.61","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1109\/TBME.2018.2882337","article-title":"Closed-loop spatial and temporal control of cavitation activity with passive acoustic mapping","volume":"66","year":"2019","journal-title":"IEEE Trans Biomed Eng"},{"key":"2024050903450681000_2023.12.21.23300222v5.62","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.2021.3115553"},{"key":"2024050903450681000_2023.12.21.23300222v5.63","doi-asserted-by":"publisher","DOI":"10.1117\/1.3360308"},{"key":"2024050903450681000_2023.12.21.23300222v5.64","doi-asserted-by":"publisher","DOI":"10.1121\/1.4712021"},{"key":"2024050903450681000_2023.12.21.23300222v5.65","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2017.1295322"},{"key":"2024050903450681000_2023.12.21.23300222v5.66","doi-asserted-by":"publisher","DOI":"10.1118\/1.3668316"},{"key":"2024050903450681000_2023.12.21.23300222v5.67","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/50\/23\/009"},{"key":"2024050903450681000_2023.12.21.23300222v5.68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/ijbs.7.1","article-title":"The application of MRI for depiction of subtle blood brain barrier disruption in stroke","volume":"7","year":"2011","journal-title":"Int J Biol Sci [Internet]"},{"key":"2024050903450681000_2023.12.21.23300222v5.69","doi-asserted-by":"crossref","unstructured":"Davies J , Siebenhandl-Wolff P , Tranquart F , Jones P , Evans P . Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration. Vol. 96, Archives of Toxicology. Springer Science and Business Media Deutschland GmbH; 2022.","DOI":"10.1007\/s00204-021-03189-8"},{"key":"2024050903450681000_2023.12.21.23300222v5.70","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.148981"},{"key":"2024050903450681000_2023.12.21.23300222v5.71","doi-asserted-by":"crossref","unstructured":"Klein G , Delmar P , Voyle N , et al. Gantenerumab reduces amyloid-\u03b2 plaques in patients with prodromal to moderate Alzheimer\u2019s disease: A PET substudy interim analysis. Vol. 11, Alzheimer\u2019s Research and Therapy. 2019.","DOI":"10.1186\/s13195-019-0559-z"},{"key":"2024050903450681000_2023.12.21.23300222v5.72","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jalz.2018.06.1353","article-title":"Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale","volume":"14","year":"2018","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2024050903450681000_2023.12.21.23300222v5.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.07.003"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.12.21.23300222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:47:12Z","timestamp":1768506432000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.12.21.23300222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,24]]},"references-count":73,"URL":"https:\/\/doi.org\/10.1101\/2023.12.21.23300222","relation":{},"subject":[],"published":{"date-parts":[[2023,12,24]]},"subtype":"preprint"}}